Skip to main content
IVFH
OTC Trade & Services

Q2 Revenue Falls 21.5% as Material Weaknesses Persist

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Consumer
Sentiment info
Negative
Importance info
8
Price
$0.245
Mkt Cap
$13.448M
52W Low
$0.21
52W High
$1.17
52W Position info
17% above low
Off High info
79% below high
Rel. Volume info
4.5× avg
Market data snapshot near publication time

IVFH sits 17% above its 52-week low of $0.21 on elevated volume (4.5× avg).

Summary

Innovative Food Holdings reported a 21.5% revenue decline in Q2 2026 and disclosed ongoing material weaknesses in internal controls, while the CEO's 1.35 million share grant remains delayed.


Key Events · Earnings and Guidance · IVFH

  • Revenue Declines 21.5%

    Q2 2026 revenue fell to $13.1 million from $16.6 million a year earlier, driven by digital channel competition and customer attrition.

  • Material Weaknesses Persist

    Management concluded disclosure controls and procedures were not effective as of June 30, 2026, due to unremediated IT general control deficiencies and account reconciliation issues.

  • CEO Stock Grant Delayed

    The 1,350,000-share Successor CEO Stock Plan grant to Gary Schubert, originally due by March 31, 2026, remains unissued; company targets completion by September 30, 2026.

  • Pennsylvania Facility Sale Completed

    The March 6, 2026 sale generated a $2.76 million gain and paid off the Maple Mark Bank term loan, with a $608,539 loss on early debt extinguishment.


Analysis · IVFH · Trade & Services

Revenue declined 21.5% to $13.1 million, driven by digital channel headwinds and customer attrition. Management disclosed that material weaknesses in IT general controls and financial reporting processes remain unremediated as of June 30, 2026. The company also revealed that the 1,350,000-share Successor CEO Stock Plan grant to Gary Schubert, originally due by March 31, 2026, has not been completed, with a new target of September 30, 2026. The sale of the Pennsylvania facility generated a $2.76 million gain and paid off the Maple Mark Bank term loan, improving cash to $1.82 million.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, IVFH was trading at $0.24 on OTC in the Trade & Services sector, with a market capitalization of approximately $13.4M. The 52-week trading range was $0.21 to $1.17. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

IVFH - Latest Insights

IVFH
Nov 12, 2026, 5:01 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.1781
Real-time Price: $0.1051 info
Change: -$0.073 (-41%) info
Market Cap: $5.775M info
IVFH
Nov 12, 2026, 4:42 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.1781
Real-time Price: $0.1051 info
Change: -$0.073 (-41%) info
Market Cap: $5.775M info
IVFH
Aug 13, 2026, 8:47 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $0.2451
Real-time Price: $0.1051 info
Change: -$0.140 (-57%) info
Market Cap: $5.775M info
IVFH
May 20, 2026, 4:06 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.2998
Real-time Price: $0.1051 info
Change: -$0.1947 (-65%) info
Market Cap: $5.775M info
IVFH
May 20, 2026, 7:09 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $0.310
Real-time Price: $0.1051 info
Change: -$0.2049 (-66%) info
Market Cap: $5.775M info